线粒体功能障碍在口腔炎症疾病的发病和治疗中的作用
Zhili Dong1,2, Liping Wu1,2, Hong Hong1,2
1Hospital of Stomatology, Sun Yat-sen University, Guangzhou 510055, China.
International journal of molecular sciences
|October 28, 2023
概括
线粒体功能障碍越来越多地与口腔炎症疾病 (OID) 和全身健康问题有关. 准线粒体功能障碍为OID提供了有前途的新治疗策略.
科学领域:
- 口腔健康 口腔健康
- 线粒体生物学 线粒体生物学
- 炎症研究 炎症研究
背景情况:
- 口腔炎症疾病 (OID),如牙周炎和牙炎,影响口腔和整体健康.
- 线粒体功能障碍与各种系统性疾病有关,影响细胞代谢和寿命.
- 新出现的证据突出显示了线粒体功能障碍在OID发展和相关系统性疾病中的作用.
研究的目的:
- 审查线粒体功能障碍在OIDs中的关键作用.
- 探索将线粒体功能障碍与OID炎症联系起来的机制.
- 总结针对OIDs线粒体功能障碍的新型治疗策略.
主要方法:
- 关于OIDs中线粒体功能障碍的最新研究的文献综述.
- 对调查线粒体功能障碍与炎症反应之间的联系的研究进行分析.
- 在OID治疗中综合了针对线粒体的治疗干预措施的信息.
主要成果:
- 线粒体功能障碍对OIDs的发病有显著的贡献.
- 线粒体功能中断会加剧口腔内的炎症反应.
- 针对线粒体功能障碍显示出新型OID治疗的潜力.
结论:
- 线粒体功能障碍是OID及其系统影响的关键因素.
- 了解这些机制可以带来更好的诊断和治疗方法.
- 未来的研究应该专注于开发针对OID的线粒体治疗方法.
相关概念视频
Electron Transport Chain: Complex I and II
14.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.2K
Mitochondrial Membranes
11.3K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
11.3K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
338
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
338
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
170
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
170
Chronic Bowel Disorders: Introduction
459
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
459
Inflammatory Bowel Disease IV: Pharmacological Management
134
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
134


